Abstract
Background: Image segmentation plays a vital role in clinical study and in diagnosing the stages of diseases. The hospitals are marching towards filmless imaging process in par with digital film technology.
Materials and Methods: The paper proposes a novel method based on morphometric segmentation algorithm with Region of Interest (ROI). The core objective is to detect better segmentation of a brain tumor from an MRI image for a clinical study.
Results and Conclusion: A set of experiment has been performed for the analysis of the proposed work on several MRI images. The proposed morphometric segmentation method provides better accuracy on segmentation of tumor image from the input MRI image.
Keywords: Brain tumor, pre-processing, segmentation, region of interest, statistical region merging, thresholding, graph cut segmentation.
Graphical Abstract
Current Signal Transduction Therapy
Title:Automated Brain Tumor Segmentation from MRI Images using Morphometric Algorithms
Volume: 15 Issue: 3
Author(s): C. Senthilkumar*R.K. Gnanamurthy
Affiliation:
- Dr. N.G.P. Institute of Technology, Coimbatore, Coimbatore, 641048, Tamil Nadu,India
Keywords: Brain tumor, pre-processing, segmentation, region of interest, statistical region merging, thresholding, graph cut segmentation.
Abstract:
Background: Image segmentation plays a vital role in clinical study and in diagnosing the stages of diseases. The hospitals are marching towards filmless imaging process in par with digital film technology.
Materials and Methods: The paper proposes a novel method based on morphometric segmentation algorithm with Region of Interest (ROI). The core objective is to detect better segmentation of a brain tumor from an MRI image for a clinical study.
Results and Conclusion: A set of experiment has been performed for the analysis of the proposed work on several MRI images. The proposed morphometric segmentation method provides better accuracy on segmentation of tumor image from the input MRI image.
Export Options
About this article
Cite this article as:
Senthilkumar C. *, Gnanamurthy R.K. , Automated Brain Tumor Segmentation from MRI Images using Morphometric Algorithms, Current Signal Transduction Therapy 2020; 15 (3) . https://dx.doi.org/10.2174/1574362414666190808090823
DOI https://dx.doi.org/10.2174/1574362414666190808090823 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of Epigenetics and Oxidative Stress in Gliomagenesis
CNS & Neurological Disorders - Drug Targets Wnt/beta-catenin and PI3K/Akt/mTOR Signaling Pathways in Glioblastoma: Two Main Targets for Drug Design: A Review
Current Pharmaceutical Design A Closer Look at α-Secretase
Current Alzheimer Research Rational Drug Design of G-Quartet DNA as Anti-Cancer Agents
Current Pharmaceutical Design Biotin-Encoded and Fe<sub>3</sub>O<sub>4</sub>-Loaded Polymeric Nano Micelles: Preparation, Optimization and In Vitro Characterization
Letters in Drug Design & Discovery Nanotechnology and Brain Tumors Drug Delivery
Recent Patents on Nanomedicine Synergistic Interplay of Medicinal Chemistry and Formulation Strategies in Nanotechnology – From Drug Discovery to Nanocarrier Design and Development
Current Topics in Medicinal Chemistry Novel Molecular Targets and Mechanisms Involved in the Invasion and Metastasis of Pancreatic Cancer
Clinical Cancer Drugs Glycogen Synthase Kinase-β3 in Ischemic Neuronal Death
Current Neurovascular Research Bcl-2 Family Proteins as Therapeutic Targets
Current Pharmaceutical Design The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain
Current Drug Targets Editorial [Hot Topic: TGF-β As Target in Oncology (Guest Editor: Karl-Hermann Schlingensiepen)]
Current Pharmaceutical Biotechnology Cellomics as Integrative Omics for Cancer
Current Proteomics Recent Progress in Discovery and Development of Antimitotic Agents
Anti-Cancer Agents in Medicinal Chemistry Epigallocatechin-3-gallate Increases RXRγ-mediated Pro-apoptotic and Anti-invasive Effects in Gastrointestinal Cancer Cell Lines
Current Cancer Drug Targets Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here
Current Drug Metabolism Lycopene: A Review of Its Potential as an Anticancer Agent
Current Medicinal Chemistry - Anti-Cancer Agents MiR-125b Inhibits Cell Proliferation and Induces Apoptosis in Human Colon Cancer SW480 Cells <i>via</i> Targeting STAT3
Recent Patents on Anti-Cancer Drug Discovery Recent Advances in Copper Radiopharmaceuticals
Current Radiopharmaceuticals Co-delivery Strategies Based on Multifunctional Nanocarriers for Cancer Therapy
Current Drug Metabolism